Current Status and Trajectory of COVID
Key Points: In today’s Recommendation for Industry, we discuss the continued westward movement of COVID in the U.S. Read more below. BA.4/5 COVID-19 variants now
Key Points: In today’s Recommendation for Industry, we discuss the continued westward movement of COVID in the U.S. Read more below. BA.4/5 COVID-19 variants now
Key Points: In today’s Recommendation for Industry, we provide current updates and recommendations on COVID and Monkeypox transmission. Read more below. COVID vaccines prevented poor
Key Points: In today’s Recommendation for Industry, we take a look at the latest statistics on COVID and expectations for the next few months. Read
Key Points: In today’s Recommendation for Industry, we provide updates on COVID-19 and Monkeypox. Read more below. Pfizer’s Omicron-Targeting COVID-19 Vaccines Generate Stronger Immune Response.
Key Points: In today’s Recommendation for Industry, we discuss the encouraging trajectory of COVID based on TAG’s matrix and CDC’s mapping. Read more below. Women
Key Points: In today’s Recommendation for Industry, we discuss the low risk of monkeypox in the US, and what businesses can do to keep it
Key Points: In today’s Recommendation for Industry, we discuss the current data on COVID case rates and hospitalizations. Read more below. FDA committee approves Moderna
Key Points: In today’s Recommendation for Industry, we discuss the recent monkeypox outbreak. Read more below. In-utero COVID exposure tied to language, motor delays by
Key Points: In today’s Recommendation for Industry, we discuss the westward movement of COVID and increase of BA.4 and BA. 5 in the U.S. Read